Literature DB >> 4168537

Pituitary-adrenal function after occlusive topical therapy with betamethasone-17-valerate.

V H James, D D Munro, M Feiwel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 4168537     DOI： 10.1016/s0140-6736(67)90336-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  Effect on adrenal function of topically applied clobetasol propionate (Dermovate).

Authors:  C F Allenby; R A Main; R A Marsden; C G Sparkes
Journal:  Br Med J       Date:  1975-12-13

2.  Clobetasone butyrate, a new topical corticosteroid: clinical activity and effects on pituitary-adrenal axis function and model of epidermal atrophy.

Authors:  D D Munro; L Wilson
Journal:  Br Med J       Date:  1975-09-13

3.  Adrenal suppression following low-dose topical clobetasol propionate.

Authors:  E M Ohman; S Rogers; F O Meenan; T J McKenna
Journal:  J R Soc Med       Date:  1987-07       Impact factor: 5.344

Review 4.  Systemic reactions to topically applied drugs. Howard Fox memorial lecture.

Authors:  F Pascher
Journal:  Bull N Y Acad Med       Date:  1973-07

5.  Editorial: Babies' blood pressure raised by eye drops.

Authors: 
Journal:  Br Med J       Date:  1974-01-05

6.  Betamethasone 17-valerate by aerosol in childhood asthma.

Authors:  J F Frears; L C Wilson; M Friedman
Journal:  Arch Dis Child       Date:  1973-11       Impact factor: 3.791

7.  Cross sectional investigation of the effects of inhaled corticosteroids on bone density and bone metabolism in patients with asthma.

Authors:  A F Wisniewski; S A Lewis; D J Green; W Maslanka; H Burrell; A E Tattersfield
Journal:  Thorax       Date:  1997-10       Impact factor: 9.139

8.  Cushing's syndrome and pituitary-adrenal suppression due to clobetasol propionate.

Authors:  R C Staughton; P J August
Journal:  Br Med J       Date:  1975-05-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.